✦ LIBER ✦

A Meta-Analysis of CYP2D6 Metabolizer Phenotype and Metoprolol Pharmacokinetics

✍ Scribed by Blake, C M; Kharasch, E D; Schwab, M; Nagele, P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of CYP2D6 Poor Metabolizer Phenot

✍ Kevin M. Sowinski; Brad S. Burlew 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

CYP2D6 phenotypes and Parkinson's diseas

✍ Lu, Yu; Peng, Qiliu; Zeng, Zhiyu; Wang, Jian; Deng, Yan; Xie, Li; Mo, Cuiju; Zen 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 427 KB

Mixture Models and Subpopulation Classif

✍ Nitin Kaila; Robert J. Straka; Richard C. Brundage 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 163 KB

Relationship between fluvoxamine pharmac

✍ O. Spigset; K. Granberg; S. Hägg; Å. Norström; R. Dahlqvist 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 155 KB

Enantiospecific pharmacokinetics of meto

✍ Angela Seeringer; Jürgen Brockmöller; Steffen Bauer; Julia Kirchheiner 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 183 KB

Evaluation of probe drugs and pharmacoki

✍ D. Frank; U. Jaehde; U. Fuhr 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 254 KB